共 50 条
- [1] Exposure-response analyses for optimal therapeutic dose selection of ABBV-383 in patients with relapsed/refractory multiple myeloma (RRMM)JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Polepally, Akshanth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyBadillo, Jesus D.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, Germanyde Almeida, Carla Biesdorf论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyD'Souza, Anita论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyBueno, Orlando Felix论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyRosenberg, Tanya论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyPothacamury, Rajvineeth Kumar论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyTalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyMenon, Rajeev论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyMensing, Sven论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, GermanyEngelhardt, Benjamin论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, Germany
- [2] Phase Ib Study Investigating the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Administration of ABBV-383 in Patients With Relapsed/Refractory Multiple MyelomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S54 - S55Gatt, Moshe论文数: 0 引用数: 0 h-index: 0机构: Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelMagen, Hila论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr, Ramat Gan, Israel Tel Aviv Univ, Sackler Fac Med & Hlth Sci, Tel Aviv, Israel Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelMcKay, John论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27101 USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelKarlin, Lionel论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Lyon Sud, Pierre Benite, France Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelTouzeau, Cyrille论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Nantes, Nantes, France Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel论文数: 引用数: h-index:机构:Kapoor, Prashant论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Rochester, Div Hematol, Rochester, MN USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelLeleu, Xavier论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Hematol, PRC, Poitiers, France Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelUchida, Toshiki论文数: 0 引用数: 0 h-index: 0机构: Nagoya Daini Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelWeisel, Katja论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelBueno, Orlando论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelRosenberg, Tanya论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelAhsan, Aarif论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelJin, Ziyi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelPolepally, Akshanth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelTalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelPothacamury, Rajvineeth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hadassah Med Ctr, Dept Hematol, Jerusalem, IsraelChhabra, Saurabh论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel
- [3] Efficacy and Safety of ABBV-383, a BCMA Bispecific Antibody, in Black Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of a Phase 1 TrialCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S48 - S48D'Souza, Anita论文数: 0 引用数: 0 h-index: 0机构: Med Coll Wisconsin, Milwaukee, WI 53226 USA Med Coll Wisconsin, Milwaukee, WI 53226 USARodriguez-Valdes, Cesar论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, New York, NY 10029 USA Med Coll Wisconsin, Milwaukee, WI 53226 USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Med Coll Wisconsin, Milwaukee, WI 53226 USAChung, Alfred论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Med Coll Wisconsin, Milwaukee, WI 53226 USATuchman, Sascha论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Chapel Hill, NC 27515 USA Med Coll Wisconsin, Milwaukee, WI 53226 USASafah, Hana论文数: 0 引用数: 0 h-index: 0机构: Tulane Canc Ctr, New Orleans, LA USA Med Coll Wisconsin, Milwaukee, WI 53226 USAWeisel, Katja论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany Med Coll Wisconsin, Milwaukee, WI 53226 USATeipel, Raphael论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Carl Gustav Carus, Dresden, Germany Med Coll Wisconsin, Milwaukee, WI 53226 USAKorde, Neha论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY 10021 USA Med Coll Wisconsin, Milwaukee, WI 53226 USAVij, Ravi论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, St Louis, MO 14263 USA Med Coll Wisconsin, Milwaukee, WI 53226 USABueno, Orlando论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USARosenberg, Tanya论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USAPothacamury, Rajvineeth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USAPolepally, Akshanth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USAAhsan, Aarif论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USALee, Shane论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USAJin, Ziyi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USASpence, Shelli论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USATalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Med Coll Wisconsin, Milwaukee, WI 53226 USAMcKay, John论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27101 USA Med Coll Wisconsin, Milwaukee, WI 53226 USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Bowman Gray Sch Med, Atrium Hlth, Levine Canc Inst, Winston Salem, NC 27101 USA Med Coll Wisconsin, Milwaukee, WI 53226 USA
- [4] Efficacy, safety, and determination of RP2D of ABBV-383, a BCMA bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Valdes, Cesar Rodriguez论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAD'Souza, Anita论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAChung, Alfred论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USATuchman, Sascha论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USASafah, Hana论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAMckay, John T.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAWeisel, Katja C.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USATeipel, Raphael论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAKorde, Neha论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAVij, Ravi论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USABueno, Orlando Felix论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USARosenberg, Tanya论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAPothacamury, Rajvineeth Kumar论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAPolepally, Akshanth论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAAhsan, Aarif论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USALi , Xin论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAJin, Ziyi论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USATalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai, Div Hematol Oncol, Dept Internal Med, New York, NY USA
- [5] ABBV-383, a BCMA-CD3 bispecific antibody, in relapsed/refractory multiple myeloma: a multicenter, phase 1b dose optimization study with step-up dosingCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S162 - S163论文数: 引用数: h-index:机构:Magen, Hila论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr, Ramat Gan, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA论文数: 引用数: h-index:机构:Jin, Ziyi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USAStrange, Elise论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USASvensson, Anders论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
- [6] CERVINO: A Phase 3, Multicenter, Randomized, Open-Label Study of ABBV-383 Compared With Standard Available Therapies in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S47 - S48Costa, Luciano论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Alabama Birmingham, Birmingham, AL USAMateos Manteca, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca, Inst Biomed Res Salamanca IBSAL, CIBERONC, Salamanca, Spain Univ Alabama Birmingham, Birmingham, AL USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Bowman Gray Sch Med, Atrium Hlth, Levine Canc Inst, Winston Salem, NC 27101 USA Univ Alabama Birmingham, Birmingham, AL USAIida, Shinsuke论文数: 0 引用数: 0 h-index: 0机构: Nagoya City Univ, Inst Med & Pharmaceut Sci, Nagoya, Aichi, Japan Univ Alabama Birmingham, Birmingham, AL USACole, Craig论文数: 0 引用数: 0 h-index: 0机构: Michigan State Univ, Karmanos Canc Inst, E Lansing, MI 48824 USA Univ Alabama Birmingham, Birmingham, AL USA论文数: 引用数: h-index:机构:Pothacamury, Rajvineeth论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Alabama Birmingham, Birmingham, AL USABueno, Orlando论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Alabama Birmingham, Birmingham, AL USALee, Shane论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Alabama Birmingham, Birmingham, AL USARosenberg, Tanya论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Alabama Birmingham, Birmingham, AL USATalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Alabama Birmingham, Birmingham, AL USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Alabama Birmingham, Birmingham, AL USA
- [7] Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myelomaNEOPLASMA, 2008, 55 (04) : 345 - 349Zemanova, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicScudla, V.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicAdam, Z.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Brno Bohunice, Internal Haematooncol Dept, Brno, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicGregora, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Kralovske Vinohrady Praha, Czech Myeloma Grp, Clin Haematol Dept, Prague, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicPour, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Brno Bohunice, Internal Haematooncol Dept, Brno, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicMinarik, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicPavlicek, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Kralovske Vinohrady Praha, Czech Myeloma Grp, Clin Haematol Dept, Prague, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicPika, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech RepublicBacovsky, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic Univ Hosp Olomouc, Dept Internal Med 3, Olomouc 77520, Czech Republic
- [8] Correlative biomarker analyses for optimal therapeutic dose determination of ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Ahsan, Aarif论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAMantis, Christine论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USALuo, Xizhi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAZhang, Catherine C.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAValdes, Cesar Rodriguez论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAVoorhees, Peter M.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAD'Souza, Anita论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAChung, Alfred论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USATuchman, Sascha论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USASafah, Hana论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAMckay, John T.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAWeisel, Katja C.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USATeipel, Raphael论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAKorde, Neha论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAVij, Ravi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAKumar, Shaji论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USABueno, Orlando Felix论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USAPothacamury, Rajvineeth Kumar论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USATalati, Chetasi论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USARoss, Jeremy A.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA
- [9] LEMZOPARLIMAB (TJ011133), AN ANTI-CD47 ANTIBODY, WITH/WITHOUT DEXAMETHASONE PLUS ANTI-MYELOMA REGIMENS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A PHASE 1B DOSE ESCALATION AND EXPANSION STUDYJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A476 - A476Stadtmauer, Edward论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAKarlin, Lionel论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Lyon Sud, Lyon, France Univ Penn, Philadelphia, PA 19104 USAWeisel, Katja论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppend, Hamburg, Germany Univ Penn, Philadelphia, PA 19104 USAGatt, Moshe Etzion论文数: 0 引用数: 0 h-index: 0机构: Hebrew Univ Jerusalem, Hadassah Med Ctr, Jerusalem, Israel Univ Penn, Philadelphia, PA 19104 USAKansagra, Ankit论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Southwestern Med, Dallas, TX USA Univ Penn, Philadelphia, PA 19104 USAMonohan, Gregory论文数: 0 引用数: 0 h-index: 0机构: Univ Kentucky, Lexington, KY USA Univ Penn, Philadelphia, PA 19104 USAYee, Andrew论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Univ Penn, Philadelphia, PA 19104 USARockow-Magnone, Shayna论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Penn, Philadelphia, PA 19104 USACordero, Jose论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Penn, Philadelphia, PA 19104 USAHoffman, David论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Penn, Philadelphia, PA 19104 USABueno, Orlando论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Penn, Philadelphia, PA 19104 USAWu, Kevin论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Univ Penn, Philadelphia, PA 19104 USAGasparetto, Cristina论文数: 0 引用数: 0 h-index: 0机构: Duke Univ Hosp, Durham, NC USA Univ Penn, Philadelphia, PA 19104 USA
- [10] Intra-patient dose escalation of panobinostat in patients with relapsed/refractory multiple myelomaLEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1277 - 1278Isoda, Atsushi论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, JapanIshikawa, Tetsuya论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, JapanMiyazawa, Yuri论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, JapanMihara, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, JapanMatsumoto, Morio论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, JapanSawamura, Morio论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, 383 Shiroi, Shibukawa, Gunma 3770280, Japan